Daily as of 3 Nov 16:00 ET
- Price
- below both $31.20 vs 50 $33.53 / 200 $31.73
- Projection
- ๐Death cross estimated in 20 to 30 bars
- Test
- No active test
- Last cross
- ๐จGolden cross 14 Jul 2026 ยท projected 27 bars out
Agios Pharmaceuticals (AGIO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2026, but the two have been closing on each other and a death cross is projected within 30 bars. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 2 Oct 2026 | ๐Death | 4-hour | 11 bars out | Not tested |
| week of 31 Aug 2026 | ๐Death flat | weekly | 10 bars out | 4 bar cross test |
| 14 Jul 2026 | ๐จGolden steep | daily | 27 bars out | Not tested |
| 18 Jun 2026 | ๐จGolden | 4-hour | 15 bars out | Not tested |
| 15 May 2026 | ๐Death | 4-hour | 29 bars out | 5 bar cross test |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.